Login
From:
Drug Discovery and Development
(Uncensored)
subscribe
Q2 net sales reach $100M for Tarsus' XDEMVY
https://www.drugdiscoverytrends.com/tarsus-cmo-on-its-silver-bullet-anti-parasitic-molecule/
links
backlinks
Tagged with:
infectious disease
drug discovery
eye care
lyme disease
anti parasitic
eye mites
lotilaner
Tarsus aims to expand the lotilaner pipeline with potential treatments for ocular rosacea, Lyme disease and malaria.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
